‘Bench-to-bedside’ describes research that has progressed from basic science in animal models that has led to therapies used in patients. Now, a study describes what could be considered a direct ‘aquarium-to-bedside’ approach, taking a drug discovered in a genetic zebrafish model of epilepsy and testing it, with promising results, in a small number of children with the disease.